The molecular biology of HIV integrase

Future Virology

Volumn 7, Issue 7, 2012, Pages 679-686

  Craigie, Robert ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

HIV 1; intasome; integrase; integration; retrovirus

Indexed keywords

BARRIER TO AUTOINTEGRATION FACTOR; INTEGRASE; LENS EPITHELIUM DERIVED GROWTH FACTOR; NUCLEOPROTEIN; OLIGONUCLEOTIDE; SMALL INTERFERING RNA; TETRAMER; VIRUS DNA;

BINDING AFFINITY; DNA BINDING; DNA INTEGRATION; DNA STRAND; HUMAN IMMUNODEFICIENCY VIRUS; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; MOLONEY LEUKEMIA ONCOVIRUS; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SPUMA VIRUS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84864463288     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.12.56     Document Type: Review

References (81)

1. Varmus H, Brown PO. Retroviruses. In: MOBILE DNA. Berg DE, Howe MM (Eds). American Society of Microbiology. Washington, DC, USA, 53-108 (1989).
2. Coffin JM, Hughes SH, Varmus HE. Retroviruses. Cold Spring Harbor Laboratory Press, NY, USA (1977).
3. Ciuffi A. Mechanisms governing lentivirus integration site selection. Curr. Gene Ther. 8(6), 419-429 (2008).
4. Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of finding a cure for HIV infection. Science 323(5919), 1304-1307 (2009).
5. Goff SP. Genetics of retroviral integration. Ann. Rev. Genet. 26, 527-544 (1992).
6. Summa V, Petrocchi A, Bonelli F et al. Discovery of Raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection. J. Med. Chem. 51(18), 5843-5855 (2008).
7. Bowerman B, Brown PO, Bishop JM, Varmus HE. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 3, 469-478 (1989).
8. Iordanskiy S, Berro R, Altieri M, Kashanchi F, Bukrinsky M. Intracytoplasmic maturation of the human immunodeficiency virus type I reverse transcription complexes determines their capacity to integrate into chromatin. Retrovirology 3, 4 (2006).
9. Bukrinsky MI, Sharova N, McDonald TL, Pushkarskaya T, Tarpley WG, Stevenson M. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl Acad. Sci. USA 90, 6125-6129 (1993).
10. Miller MD, Farnet CM, Bushman FD. Human immunodeficiency virus type 1 preintegration complexes: Studies of organization and composition. J. Virol. 71(7), 5382-5390 (1997).
11. Farnet CM, Haseltine WA. Integration of human immunodeficiency virus type 1 DNA in vitro. Proc. Natl. Acad. Sci. USA 87, 4164-4168 (1990).
12. Farnet CM, Bushman FD. HIV-1 cDNA integration: Requirement of HMG I(Y) protein for function of preintegration complexes in vitro. Cell 88, 483-492 (1997).
13. Farnet CM, Haseltine WA. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J. Virol. 65, 1910-1915 (1991).
14. Karageorgos L, Li P, Burrell C. Characterization of HIV replication complexes early after cell-to-cell infection. AIDS Res. Hum. Retrovir. 9(9), 817-823 (1993).
15. Gallay P, Swingler S, Song JP, Bushman F, Trono D. HIV nuclear import Is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83(4), 569-576 (1995).
16. Brown PO, Bowerman B, Varmus HE, Bishop JM. Correct integration of retroviral DNA in vitro. Cell 49, 347-356 (1987).
17. Ellison V, Abrams H, Roe T, Lifson J, Brown P. Human immunodeficiency virus integration in a cell-free system. J. Virol. 64, 2711-2715 (1990).
18. Fujiwara T, Mizuuchi K. Retroviral DNA integration: Structure of an integration intermediate. Cell 54, 497-504 (1988).
19. Brown PO, Bowerman B, Varmus HE, Bishop JM. Retroviral integration: Structure of the initial covalent product and its precursor, and a role for the viral IN protein. Proc. Natl Acad. Sci. USA 86, 2525-2529 (1989).
20. Katzman M, Katz RA, Skalka AM, Leis J. The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration. J. Virol. 63, 5319-5327 (1989).
21. Craigie R, Fujiwara T, Bushman F. The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell 62, 829-837 (1990).
22. Katz RA, Merkel G, Kulkosky J, Leis J, Skalka AM. The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell 63, 87-95 (1990).
23. Engelman A, Mizuuchi K, Craigie R. HIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer. Cell 67, 1211-1221 (1991).
24. Engelman A, Craigie R. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J. Virol. 66, 6361-6369 (1992).
25. Kulkosky J, Jones KS, Katz RA, Mack JP, Skalka AM. Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/ retrotransposon integrases and bacterial insertion sequence transposases. Mol. Cell Biol. 12, 2331-2338 (1992).
26. van Gent DC, Groeneger AA, Plasterk RH. Mutational analysis of the integrase protein of human immunodeficiency virus type 2. Proc. Natl Acad. Sci. USA 89, 9598-9602 (1992).
27. Leavitt AD, Shiue L, Varmus HE. Site-directed mutagenesis of HIV-1 integrase demonstrates differential effects on integrase functions in vitro. J. Biol. Chem. 268, 2113-2119 (1993).
28. van Gent DC, Elgersma Y, Bolk MW, Vink C, Plasterk RH. DNA binding properties of the integrase proteins of human immunodeficiency viruses types 1 and 2. Nucleic Acids Res. 19, 3821-3827 (1991).
29. Bushman FD, Craigie R. Activities of human immunodeficiency virus (HIV) integration protein in vitro: Specific cleavage and integration of HIV DNA. Proc. Natl Acad. Sci. USA 88, 1339-1343 (1991).
30. Aiyar A, Hindmarsh P, Skalka AM, Leis J. Concerted integration of linear retroviral DNA by the avian sarcoma virus integrase in vitro: DEPENDENCE on both long terminal repeat termini. J. Virol. 70(6), 3571-3580 (1996).
31. Sinha S, Pursley MH, Grandgenett DP. Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors. J. Virol. 76(7), 3105-3113 (2002).
32. Li M, Craigie R. Processing the viral DNA ends channels the HIV-1 integration reaction to concerted integration. J. Biol. Chem. 280, 29334-29339 (2005).
33. Sinha S, Grandgenett DP. Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells. J. Virol. 79(13), 8208-8216 (2005).
34. Pandey KK, Bera S, Grandgenett DP. The HIV-1 Integrase monomer induces a specific interaction with LTR DNA for concerted integration. Biochemistry 50(45), 9788-9796 (2011).
35. Li M, Mizuuchi M, Burke TR, Craigie R. Retroviral DNA integration: Reaction pathway and critical intermediates. EMBO J. 25(6), 1295-1304 (2006).
36. Li M, Ivanov V, Mizuuchi M, Mizuuchi K, Craigie R. DNA requirements for assembly and stability of HIV-1 intasomes. Protein Sci. 21, 249-257 (2012).
37. Kotova S, Li M, Dimitriadis EK, Craigie R. Nucleoprotein intermediates in HIV-1 DNA integration visualized by atomic force microscopy. J. Mol. Biol. 399(3), 491-500 (2010).
38. Beare KD, Coster MJ, Rutledge PJ. Diketoacid inhibitors of HIV-1 integrase: FROM L-708,906 to Raltegravir and beyond. Curr. Med. Chem. 19(8), 1177-1192 (2012).
39. Espeseth AS, Felock P, Wolfe A et al. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase. Proc. Natl Acad. Sci. USA 97(21), 11244-11249 (2000).
40. De Luca L, Ferro S, Gitto R et al. Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. Bioorg. Med. Chem. 18(21), 7515-7521 (2010).
41. De Luca L, Ferro S, Morreale F, De Grazia S, Chimirri A. Inhibitors of the interactions between HIV-1 IN and the cofactor LEDGF/ p75. Chem. Med. Chem. 6(7), 1184-1191 (2011).
42. Kessl J, Jena N, Koh Y et al. A multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitors. J. Biol. Chem. 287(20), 16801-16811 (2012).
43. Hare S, Gupta SS, Valkov E, Engelman A, Cherepanov P. Retroviral intasome assembly and inhibition of DNA strand transfer. Nature 464, 232-236 (2010).
44. Maertens GN, Hare S, Cherepanov P. The mechanism of retroviral integration from X-ray structures of its key intermediates. Nature 468(7321), 326-329 (2010).
45. Dyda F, Hickman AB, Jenkins TM, Engelman A, Craigie R, Davies DR. Crystal structure of the catalytic domain of HIV-1 integrase: Similarity to other polynucleotidyl transferases. Science 266, 1981-1986 (1994).
46. Bujacz G, Jaskolski M, Alexandratos J et al. High-resolution structure of the catalytic domain of avian sarcoma virus integrase. J. Mol. Biol. 253, 333-346 (1995).
47. Cai M, Zheng R, Caffrey M, Craigie R, Clore GM, Gronenborn AM. Solution structure of the N-terminal zinc binding domain of HIV-1 integrase. Nat. Struct. Biol. 4, 567-577 (1997).
48. Eijkelenboom AP, van Den Ent FM, Vos A et al. The solution structure of the amino-terminal HHCC domain of HIV-2 integrase: A three-helix bundle stabilized by zinc. Curr. Biol. 7, 739-746 (1997).
49. Eijkelenboom AP, Lutzke RA, Boelens R, Plasterk RH, Kaptein R, Hard K. The DNA-binding domain of HIV-1 integrase has an SH3-like fold. Nat. Struct. Biol. 2, 807-810 (1995).
50. Lodi PJ, Ernst JA, Kuszewski J et al. Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry 34, 9826-9833 (1995).
51. Chiu TK, Davies DR. Structure and function of HIV-1 integrase. Curr. Top. Med. Chem. 4(9), 965-977 (2004).
52. Jaskolski M, Alexandratos JN, Bujacz G, Wlodawer A. Piecing together the structure of retroviral integrase, an important target in AIDS therapy. FEBS J. 276(11), 2926-2946 (2009).
53. Valkov E, Gupta SS, Hare S et al. Functional and structural characterization of the integrase from the prototype foamy virus. Nucleic Acids Res. 37(1), 243-255 (2009).
54. Davies DR, Goryshin IY, Reznikoff WS, Rayment I. Three-dimensional structure of the Tn5 synaptic complex transposition intermediate. Science 289, 77-85 (2000).
55. Krishnan L, Li XA, Naraharisetty HL, Hare S, Cherepanov P, Engelman A. Structure-based modeling of the functional HIV-1 intasome and its inhibition. Proc. Natl Acad. Sci. USA 107(36), 15910-15915 (2010).
56. Hare S, Vos AM, Clayton RF, Thuring JW, Cummings MD, Cherepanov P. Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance. Proc. Natl Acad. Sci. USA 107(46), 20057-20062 (2010).
57. Bushman F, Lewinski M, Ciuffi A et al. Genome wide analysis of retroviral DNA integration. Nat. Rev. Microbiol. 3(11), 848-858 (2005).
58. Greene WC, Peterlin BM. Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy. Nat. Med. 8(7), 673-680 (2002).
59. Suzuki Y, Craigie R. The road to chromatin - nuclear entry of retroviruses. Nat. Rev. Microbiol. 5(3), 187-196 (2007).
60. Van Maele B, Busschots K, Vandekerckhove L, Christ F, Debyser Z. Cellular co-factors of HIV-1 integration. Trends Biochem. Sci. 31(2), 98-105 (2006).
61. Engelman A, Cherepanov P. The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication. PLoS Pathog. 4(3), e1000046 (2008).
62. Poeschla EM. Integrase, LEDGF/p75 and HIV replication. Cell. Mol. Life Sci. 65(9), 1403-1424 (2008).
63. Cherepanov P, Maertens G, Proost P et al. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J. Biol. Chem. 278(1), 372-381 (2003).
64. Turlure F, Devroe E, Silver PA, Engelman A. Human cell proteins and human immunodeficiency virus DNA integration. Front. Biosci. 9, 3187-3208 (2004).
65. Llano M, Saenz DT, Meehan A et al. An essential role for LEDGF/p75 in HIV integration. Science 314(5798), 461-464 (2006).
66. Shun MC, Raghavendra NK, Vandegraaff N et al. LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev. 21(14), 1767-1778 (2007).
67. Vandekerckhove L, Christ F, Van Maele B et al. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus. J. Virol. 80(4), 1886-1896 (2006).
68. Schroder ARW, Shinn P, Chen HM, Berry C, Ecker JR, Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110(4), 521-529 (2002).
69. De Rijck J, Bartholomeeusen K, Ceulemans H, Debyser Z, Gijsbers R. High-resolution profiling of the LEDGF/p75 chromatin interaction in the ENCODE region. Nucleic Acids Res. 38(18), 6135-6147 (2010).
70. Vanegas M, Llano M, Delgado S, Thompson D, Peretz M, Poeschla E. Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering. J. Cell. Sci. 118(8), 1733-1743 (2005).
71. Cherepanov P, Devroe E, Silver PA, Engelman A. Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase. J. Biol. Chem. 279(47), 48883-48892 (2004).
72. Cherepanov P, Ambrosio ALB, Rahman S, Ellenberger T, Engelman A. Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. Proc. Natl Acad. Sci. USA 102(48), 17308-17313 (2005).
73. Christ F, Voet A, Marchand A et al. Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication. Nat. Chem. Biol. 6(6), 442-448 (2010).
74. Llano M, Vanegas M, Hutchins N, Thompson D, Delgado S, Poeschla EM. Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75. J. Mol. Biol. 360(4), 760-773 (2006).
75. Turlure F, Maertens G, Rahman S, Cherepanov P, Engelman A. A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/ p75 with chromatin in vivo. Nucleic Acids Res. 34(5), 1653-1665 (2006).
76. Lee MS, Craigie R: PROTECTION of retroviral DNA from autointegration: Involvement of a cellular factor. Proc. Natl Acad. Sci. USA 91, 9823-9827 (1994).
77. Lee MS, Craigie R: A previously unidentified host protein protects retroviral DNA from autointegration. Proc. Natl Acad. Sci. USA 95, 1528-1533 (1998).
78. Zheng RL, Ghirlando R, Lee MS, Mizuuchi K, Krause M, Craigie R. Barrier-to-autointegration factor (BAF) bridges DNA in a discrete, higher-order nucleoprotein complex. Proc. Natl Acad. Sci. USA 97(16), 8997-9002 (2000).
79. Skoko D, Li M, Huang Y et al. Barrier-to-autointegration factor (BAF) condenses DNA by looping. Proc. Natl Acad. Sci. USA 106(39), 16610-16615 (2009).
80. Lee K, Ambrose Z, Martin TD et al. Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 7(3), 221-233 (2010).
81. Yin Z, Craigie R. Modeling the HIV-1 intasome: A prototype view of the target of integrase inhibitors. Viruses; 2(12), 2777-2781 (2010).